Diethylcarbamazine overdosage
| Diethylcarbamazine |
|---|
| HETRAZAN® WHO Prescribing Information |
| Description |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Overdosage |
| Dosage and Administration |
| How Supplied |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overdosage
Nausea, vomiting, headache, dizziness and drowsiness are characteristic. In severe cases convulsions may occur, requiring treatment with parenteral diazepam. Treatment is otherwise supportive and symptomatic.[1]
References
Adapted from the FDA Package Insert.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH